Home monitoring and self-management of blood pressure in chronic kidney disease

Not Applicable

• Conditions: Renal and urogenital; Urological and Genital Diseases

• Registration Number: ISRCTN56336493
• Lead Sponsor: niversity Hospitals of Derby and Burton NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-09
• Last Update Posted: 21 May 2024
• Study Completion: 2025-12-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

1. Capable of giving informed consent
2. >=18 years
3. Chronic kidney disease stages 1-4 looked after in secondary care nephrology
4. Standardised office systolic BP >120 mmHg or >130 mmHg with diabetes

Exclusion Criteria

1. Evidence of postural hypotension defined as standing BP < 110mmHg, significant postural drop in BP (> 20mmHg) or patient reported symptoms
2. Currently taking > = 4 antihypertensive medications – due to limited scope to up titrate medication.
3. Memory impairment or dementia – such that would prevent the ability to self- monitor and manage medication safely.
4. Pregnancy or breastfeeding or intending pregnancy in trial period – due to different BP targets and medication used in hypertension during pregnancy and limitations on drugs used.
5. Estimated date of requiring dialysis (EDD) within the next 6 months – this is due to the increased risk of side effects and electrolyte abnormalities in titrating medication in this group and the likelihood of completing the 12 month follow up period (most anti-hypertensives are stopped once participants commence dialysis).
6. Renal transplant recipients

Study & Design

• Study Type: Interventional
• Study Design: Not specified